ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | -40.0% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $5,000 | -44.4% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | -30.8% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $13,000 | -27.8% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | +38.5% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $13,000 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | -18.8% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $16,000 | +33.3% | 5,000 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $12,000 | -50.0% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $24,000 | +14.3% | 5,000 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $21,000 | -27.6% | 5,000 | 0.0% | 0.00% | -40.0% |
| Q2 2019 | $29,000 | +52.6% | 5,000 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $19,000 | +111.1% | 5,000 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $9,000 | – | 5,000 | +6072.8% | 0.00% | – |
| Q1 2018 | $0 | – | 81 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |